Hemophilia affects approximately 24,000 Americans, making it one of the rarer conditions primary care clinicians will encounter. Most cases are hereditary and managed in partnership with specialty hemophilia treatment centers. An exception that is important to recognize is Acquired Hemophilia A — an autoimmune form that emerges most often in adults around age 75 with no prior bleeding history, and carries mortality exceeding 20% in older patients. Recognizing it requires knowing it exists.
AAVBC's Hemophilia Quick Reference Guide gives care teams a concise reference for both hereditary and acquired hemophilia, covering factor type and severity classification, inhibitor status documentation, ICD-10 coding, comorbidity management, and MEAT documentation standards — grounded in current WFH and ASH guideline evidence.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of hemophilia — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Hemophilia affects approximately 24,000 Americans, making it one of the rarer conditions primary care clinicians will encounter. Most cases are hereditary and managed in partnership with specialty hemophilia treatment centers. An exception that is important to recognize is Acquired Hemophilia A — an autoimmune form that emerges most often in adults around age 75 with no prior bleeding history, and carries mortality exceeding 20% in older patients. Recognizing it requires knowing it exists.
AAVBC's Hemophilia Quick Reference Guide gives care teams a concise reference for both hereditary and acquired hemophilia, covering factor type and severity classification, inhibitor status documentation, ICD-10 coding, comorbidity management, and MEAT documentation standards — grounded in current WFH and ASH guideline evidence.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of hemophilia — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
